Harbour Capital Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Sell
9,586
-80
-0.8% -$29.7K 0.74% 31
2026
Q1
$3.42M Sell
9,666
-40
-0.4% -$11.9K 0.65% 43
2025
Q4
$3.27M Sell
9,706
-75
-0.8% -$25.4K 0.66% 41
2025
Q3
$3.56M Sell
9,781
-1,984
-17% -$600K 0.73% 38
2025
Q2
$3.62M Sell
11,765
-51
-0.4% -$19.5K 0.76% 37
2025
Q1
$6.39M Sell
11,816
-42
-0.4% -$21.5K 1.58% 13
2024
Q4
$6.08M Sell
11,858
-9
-0.1% -$5.11K 1.36% 14
2024
Q3
$7.02M Sell
11,867
-1,802
-13% -$1.02M 1.62% 13
2024
Q2
$6.76M Buy
13,669
+54
+0.4% +$26.5K 1.6% 13
2024
Q1
$6.24M Buy
13,615
+72
+0.5% +$36.6K 1.54% 12
2023
Q4
$7.34M Sell
13,543
-24
-0.2% -$12.8K 2.01% 9
2023
Q3
$6.84M Sell
13,567
-1,698
-11% -$836K 2.05% 8
2023
Q2
$7.29M Sell
15,265
-269
-2% -$132K 2.15% 6
2023
Q1
$7.35M Buy
15,534
+283
+2% +$137K 2.22% 4
2022
Q4
$7.91M Sell
15,251
-661
-4% -$350K 2.66% 4
2022
Q3
$7.94M Sell
15,912
-186
-1% -$97.8K 2.75% 4
2022
Q2
$8.27M Buy
16,098
+116
+0.7% +$58.3K 2.7% 4
2022
Q1
$8.15M Buy
15,982
+77
+0.5% +$37.1K 2.23% 5
2021
Q4
$7.99M Buy
15,905
+297
+2% +$134K 1.96% 6
2021
Q3
$6.1M Buy
15,608
+165
+1% +$68.3K 1.61% 11
2021
Q2
$6.18M Buy
15,443
+115
+0.8% +$45.9K 1.66% 11
2021
Q1
$5.7M Buy
15,328
+138
+0.9% +$47.8K 1.68% 10
2020
Q4
$5K Buy
15,190
+384
+3% +$129K 2.49% 16
2020
Q3
$4.62M Buy
14,806
+305
+2% +$93.7K 1.69% 10
2020
Q2
$4.28M Buy
14,501
+7
+0% +$2.01K 1.73% 9
2020
Q1
$3.62M Buy
14,494
+323
+2% +$88.9K 1.84% 8
2019
Q4
$4.17M Buy
14,171
+13
+0.1% +$3.4K 1.6% 10
2019
Q3
$3.08M Buy
14,158
+824
+6% +$199K 1.3% 17
2019
Q2
$3.25M Buy
13,334
+9
+0.1% +$2.17K 1.4% 15
2019
Q1
$3.29M Buy
13,325
+4
+0% +$1.02K 1.46% 11
2018
Q4
$3.32M Sell
13,321
-37
-0.3% -$9.77K 1.65% 10
2018
Q3
$3.55M Sell
13,358
-13
-0.1% -$3.38K 1.43% 12
2018
Q2
$3.31M Sell
13,371
-41
-0.3% -$9.85K 1.42% 12
2018
Q1
$2.87M Sell
13,412
-654
-5% -$149K 1.22% 15
2017
Q4
$3.1M Buy
14,066
+238
+2% +$50.4K 1.29% 10
2017
Q3
$2.71M Buy
13,828
+255
+2% +$49.3K 1.18% 13
2017
Q2
$2.52M Sell
13,573
-43
-0.3% -$7.54K 1.25% 11
2017
Q1
$2.23M Buy
13,616
+370
+3% +$60.6K 1.02% 15
2016
Q4
$2.12M Buy
13,246
+1,236
+10% +$185K 1.52% 8
2016
Q3
$1.68M Sell
12,010
-28
-0.2% -$3.92K 1.05% 13
2016
Q2
$1.7M Sell
12,038
-200
-2% -$26.7K 0.95% 18
2016
Q1
$1.58M Sell
12,238
-90
-0.7% -$10.6K 0.9% 23
2015
Q4
$1.45M Buy
12,328
+1,275
+12% +$149K 0.79% 28
2015
Q3
$1.28M Buy
11,053
+40
+0.4% +$4.79K 0.91% 22
2015
Q2
$1.34M Buy
11,013
+2,300
+26% +$272K 0.84% 22
2015
Q1
$1.03M Buy
8,713
+1,725
+25% +$192K 0.72% 33
2014
Q4
$706K Buy
6,988
+900
+15% +$85.3K 0.51% 73
2014
Q3
$525K Buy
6,088
+2,440
+67% +$206K 0.43% 92
2014
Q2
$298K Buy
+3,648
New +$287K 0.23% 150

Other funds holding UNH

Harbour Capital Advisors's UNH Position: Q2 2026 in Review

Harbour Capital Advisors reduced its UnitedHealth (UNH) stake by 0.83% in Q2 2026, selling an estimated $29.7K and leaving 9,586 shares worth $4.07M. The position accounts for 0.74% of the portfolio, ranked #31.

Harbour Capital Advisors first reported a position in UNH in Q2 2014 and has held it in 49 quarters since. The position peaked at $8.27M in Q2 2022. 889 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Harbour Capital Advisors held 9,586 shares of UnitedHealth worth $4.07M as of Q2 2026.
  • Harbour Capital Advisors sold 80 UnitedHealth shares in Q2 2026, an estimated $29.7K.
  • UnitedHealth made up 0.74% of Harbour Capital Advisors's portfolio in Q2 2026, its #31 holding.
  • Harbour Capital Advisors first reported a position in UnitedHealth in Q2 2014 and has held it in 49 quarters since.
  • Harbour Capital Advisors's UnitedHealth position peaked at $8.27M in Q2 2022.
  • 889 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.